Flora Growth (FLGC) Competitors $26.24 +0.84 (+3.29%) As of 10:38 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FLGC vs. INMB, BRNS, ATNM, FGEN, TPST, VRCA, LTRN, PEPG, NBRV, and RNXTShould you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include INmune Bio (INMB), Barinthus Biotherapeutics (BRNS), Actinium Pharmaceuticals (ATNM), FibroGen (FGEN), Tempest Therapeutics (TPST), Verrica Pharmaceuticals (VRCA), Lantern Pharma (LTRN), PepGen (PEPG), Nabriva Therapeutics (NBRV), and RenovoRx (RNXT). These companies are all part of the "pharmaceutical products" industry. Flora Growth vs. Its Competitors INmune Bio Barinthus Biotherapeutics Actinium Pharmaceuticals FibroGen Tempest Therapeutics Verrica Pharmaceuticals Lantern Pharma PepGen Nabriva Therapeutics RenovoRx INmune Bio (NASDAQ:INMB) and Flora Growth (NASDAQ:FLGC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability. Which has more risk and volatility, INMB or FLGC? INmune Bio has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500. Comparatively, Flora Growth has a beta of 1.97, indicating that its share price is 97% more volatile than the S&P 500. Do analysts prefer INMB or FLGC? INmune Bio currently has a consensus target price of $18.40, suggesting a potential upside of 831.65%. Flora Growth has a consensus target price of $93.00, suggesting a potential upside of 254.49%. Given INmune Bio's higher probable upside, equities analysts plainly believe INmune Bio is more favorable than Flora Growth.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score INmune Bio 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.57Flora Growth 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is INMB or FLGC more profitable? INmune Bio has a net margin of 0.00% compared to Flora Growth's net margin of -24.86%. INmune Bio's return on equity of -120.62% beat Flora Growth's return on equity.Company Net Margins Return on Equity Return on Assets INmune BioN/A -120.62% -92.94% Flora Growth -24.86%-261.57%-48.06% Does the media favor INMB or FLGC? In the previous week, INmune Bio had 2 more articles in the media than Flora Growth. MarketBeat recorded 4 mentions for INmune Bio and 2 mentions for Flora Growth. Flora Growth's average media sentiment score of 1.46 beat INmune Bio's score of 1.35 indicating that Flora Growth is being referred to more favorably in the news media. Company Overall Sentiment INmune Bio Positive Flora Growth Positive Do institutionals and insiders hold more shares of INMB or FLGC? 12.7% of INmune Bio shares are held by institutional investors. Comparatively, 36.0% of Flora Growth shares are held by institutional investors. 35.7% of INmune Bio shares are held by insiders. Comparatively, 12.6% of Flora Growth shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has stronger earnings & valuation, INMB or FLGC? Flora Growth has higher revenue and earnings than INmune Bio. INmune Bio is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioINmune Bio$50K1,050.11-$42.08M-$2.48-0.80Flora Growth$59.51M0.26-$15.91M-$34.38-0.76 SummaryINmune Bio beats Flora Growth on 9 of the 17 factors compared between the two stocks. Get Flora Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLGC vs. The Competition Export to ExcelMetricFlora GrowthMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.22M$10.50B$5.72B$10.26BDividend YieldN/A1.86%5.72%4.60%P/E Ratio-0.7620.5875.1426.27Price / Sales0.2629.78513.55173.47Price / CashN/A25.0025.8129.90Price / Book2.153.4413.536.28Net Income-$15.91M$210.63M$3.28B$270.21M7 Day Performance14.64%-1.47%0.01%1.69%1 Month Performance11.01%1.58%4.45%5.84%1 Year Performance-35.93%-11.29%76.84%25.21% Flora Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLGCFlora Growth3.2826 of 5 stars$26.24+3.3%$93.00+254.5%-32.4%$15.22M$59.51M-0.76280Positive NewsShort Interest ↓Gap UpINMBINmune Bio3.4935 of 5 stars$1.81-7.2%$18.40+916.6%-63.9%$51.84M$10K-0.7310News CoverageNegative NewsShort Interest ↓BRNSBarinthus Biotherapeutics2.7609 of 5 stars$1.22-2.0%$3.00+146.9%-17.3%$50.49M$14.97M-0.70107ATNMActinium Pharmaceuticals2.223 of 5 stars$1.60+1.3%$4.50+181.3%-12.9%$49.91MN/A-1.1530FGENFibroGen4.4662 of 5 stars$11.16-7.8%$43.00+285.3%+0.8%$48.93M$29.62M-29.37570News CoverageAnalyst UpgradeGap DownTPSTTempest Therapeutics2.4789 of 5 stars$10.85-1.3%$30.00+176.5%-47.4%$48.80MN/A-0.7420VRCAVerrica Pharmaceuticals4.0758 of 5 stars$5.06-1.0%$80.00+1,481.0%-74.9%$48.22M$7.57M-0.6140Positive NewsLTRNLantern Pharma2.3786 of 5 stars$4.06-5.8%$25.00+515.8%-5.2%$46.54MN/A-2.2820Gap UpTrading HaltedPEPGPepGen2.836 of 5 stars$1.49+6.4%$7.67+414.5%-83.2%$45.92MN/A-0.5030NBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070RNXTRenovoRx2.3478 of 5 stars$1.14-8.1%$7.50+557.9%+12.8%$45.44M$40K-3.006Short Interest ↑Gap Up Related Companies and Tools Related Companies INMB Competitors BRNS Competitors ATNM Competitors FGEN Competitors TPST Competitors VRCA Competitors LTRN Competitors PEPG Competitors NBRV Competitors RNXT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLGC) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flora Growth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Flora Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
